{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,3]],"date-time":"2026-03-03T22:38:40Z","timestamp":1772577520199,"version":"3.50.1"},"reference-count":33,"publisher":"Springer Science and Business Media LLC","issue":"2","license":[{"start":{"date-parts":[[2007,6,27]],"date-time":"2007-06-27T00:00:00Z","timestamp":1182902400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Endocr Pathol"],"published-print":{"date-parts":[[2007,9,25]]},"DOI":"10.1007\/s12022-007-0014-8","type":"journal-article","created":{"date-parts":[[2007,6,26]],"date-time":"2007-06-26T10:03:02Z","timestamp":1182852182000},"page":"79-85","source":"Crossref","is-referenced-by-count":41,"title":["Differential Expression of the Five Somatostatin Receptor Subtypes in Human Benign and Malignant Insulinomas \u2013 Predominance of Receptor Subtype 4"],"prefix":"10.1007","volume":"18","author":[{"given":"Guida Maria","family":"Portela-Gomes","sequence":"first","affiliation":[]},{"given":"Mats","family":"Stridsberg","sequence":"additional","affiliation":[]},{"given":"Lars","family":"Grimelius","sequence":"additional","affiliation":[]},{"given":"Otto","family":"Rorstad","sequence":"additional","affiliation":[]},{"given":"Eva Tiensuu","family":"Janson","sequence":"additional","affiliation":[]}],"member":"297","published-online":{"date-parts":[[2007,6,27]]},"reference":[{"key":"14_CR1","doi-asserted-by":"crossref","first-page":"1067","DOI":"10.1139\/o74-148","volume":"52","author":"P Brazeau","year":"1974","unstructured":"Brazeau P, Vale W, Burgus R, Guillemin R. Isolation of somatostatin (a somatotropin release inhibiting factor) of ovine hypothalamic origin. Can J Biochem 52:1067\u201372, 1974.","journal-title":"Can J Biochem"},{"key":"14_CR2","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1073\/pnas.89.1.251","volume":"89","author":"Y Yamada","year":"1992","unstructured":"Yamada Y, Post SR, Wang K, Tager HS, Bell GI, Seino, S. Cloning and functional characterization of a family of human and mouse somatostatin receptors expressed in brain, gastrointestinal tract, and kidney. Proc Natl Acad Sci U S A 89:251\u20135, 1992.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14_CR3","first-page":"2136","volume":"6","author":"Y Yamada","year":"1992","unstructured":"Yamada Y, Reisine T, Law SF, Ihara Y, Kubota A, Kagimoto S, et al. Somatostatin receptors, an expanding gene family: cloning and functional characterization of human SSTR3, a protein coupled to adenylyl cyclase. Mol Endocrinol 6:2136\u201342, 1992.","journal-title":"Mol Endocrinol"},{"key":"14_CR4","doi-asserted-by":"crossref","first-page":"844","DOI":"10.1006\/bbrc.1993.2122","volume":"195","author":"Y Yamada","year":"1993","unstructured":"Yamada Y, Kagimoto S, Kubota A, Yasuda, K, Masuda K, Someya Y, et al. Cloning, functional expression and pharmacological characterization of a fourth (hSSTR4) and a fifth (hSSTR5) human somatostatin receptor subtype. Biochem Biophys Res Commun 195:844\u201352, 1993.","journal-title":"Biochem Biophys Res Commun"},{"key":"14_CR5","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1073\/pnas.91.6.2315","volume":"91","author":"L Buscail","year":"1994","unstructured":"Buscail L, Delesque N, Est\u00e8ve JP, Saint-Laurent N, Prats H, Clerc P, et al. Stimulation of tyrosine phosphatase and inhibition of cell proliferation by somatostatin analogues: mediation by human somatostatin receptor subtypes sstR1 and sstR2. Proc Natl Acad Sci U S A 91:2315\u20139, 1994.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14_CR6","doi-asserted-by":"crossref","first-page":"1580","DOI":"10.1073\/pnas.92.5.1580","volume":"92","author":"L Buscail","year":"1995","unstructured":"Buscail L, Est\u00e8ve JP, Saint-Laurent N, Bertrand V, Reisine T, O\u2019Carroll A, et al. Inhibition of cell proliferation by the somatostatin analogue RC-160 is mediated by somatostatin receptor subtypes sstr2 and sstr5 through different mechanisms. Proc Natl Acad Sci U S A 92:1580\u20134, 1995.","journal-title":"Proc Natl Acad Sci U S A"},{"key":"14_CR7","first-page":"1688","volume":"10","author":"K Sharma","year":"1996","unstructured":"Sharma K, Patel YC, Srikant CB. Subtype-selective induction of wild-type p53 and apoptosis, but not cell cycle arrest, by human somatostatin receptor 3. Mol Endocrinol 10:1688\u201396, 1996.","journal-title":"Mol Endocrinol"},{"key":"14_CR8","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1159\/000047824","volume":"12","author":"R Teijeiro","year":"2002","unstructured":"Teijeiro R, Rios R, Costoya JA, Castro R, Bello JL, Devesa J, et al. Activation of human somatostatin receptor 2 promotes apoptosis through a mechanism that is independent from induction of p53. Cell Physiol Biochem 12:31\u20138, 2002.","journal-title":"Cell Physiol Biochem"},{"key":"14_CR9","doi-asserted-by":"crossref","first-page":"157","DOI":"10.1006\/frne.1999.0183","volume":"20","author":"YC Patel","year":"1999","unstructured":"Patel YC. Somatostatin and its receptor family. Front Neuroendocrinol 20:157\u201398, 1999.","journal-title":"Front Neuroendocrinol"},{"key":"14_CR10","doi-asserted-by":"crossref","first-page":"707","DOI":"10.1530\/eje.0.1460707","volume":"146","author":"C Bruns","year":"2002","unstructured":"Bruns C, Lewis I, Briner U, Meno-Tetang G, Weckbecker G. SOM230: a novel somatostatin peptidomimetic with broad somatotropin release inhibiting factor (SRIF) receptor binding and a unique antisecretory profile. Eur J Endocrinol 146:707\u201316, 2002.","journal-title":"Eur J Endocrinol"},{"key":"14_CR11","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-642-59655-1","volume-title":"Histological typing of endocrine tumors. WHO international histological classification of tumours","author":"E Solcia","year":"2000","unstructured":"Solcia E, Kl\u00f6ppel G, Sobin LH, Capella C, DeLellis RA, Heitz PU, et al. Histological typing of endocrine tumors. 2nd ed. WHO international histological classification of tumours. Berlin: Springer; 2000.","edition":"2"},{"key":"14_CR12","doi-asserted-by":"crossref","first-page":"535","DOI":"10.1016\/S0921-4410(03)21025-5","volume":"21","author":"ET Janson","year":"2003","unstructured":"Janson ET, \u00d6berg K. Neuroendocrine tumors\u2014somatostatin receptor expression and somatostatin analog treatment. Cancer Chemother Biol Response Modif Annu 21:535\u201346, 2003.","journal-title":"Cancer Chemother Biol Response Modif Annu"},{"issue":"11 suppl","key":"14_CR13","first-page":"132","volume":"28","author":"WW Herder de","year":"2005","unstructured":"de Herder WW, Kwekkeboom DJ, Valkema R, Feelders RA, van Aken MO, Lamberts SW, et al. Neuroendocrine tumors and somatostatin: imaging techniques. J Endocrinol Investig 28 (11 suppl):132\u20136, 2005.","journal-title":"J Endocrinol Investig"},{"key":"14_CR14","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1530\/eje.1.01901","volume":"152","author":"D Vezzosi","year":"2005","unstructured":"Vezzosi D, Bennet A, Rochaix P, Courbon F, Selves J, Pradere B, et al. Octreotide in insulinoma patients: efficacy on hypoglycaemia, relationship with Octreoscan scintigraphy and immunostaining with anti-sst2A and anti-sst5 antibodies. Eur J Endocrinol 152:757\u201367, 2005.","journal-title":"Eur J Endocrinol"},{"key":"14_CR15","first-page":"459","volume":"41","author":"O Schillaci","year":"2000","unstructured":"Schillaci O, Massa R, Scopinaro F. 111In-pentrotide scintigraphy in the detection of insulinomas: importance of SPECT imaging. J Nucl Med 41:459\u201362, 2000.","journal-title":"J Nucl Med"},{"key":"14_CR16","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1046\/j.1365-2168.2001.01644.x","volume":"88","author":"GD Slooter","year":"2001","unstructured":"Slooter GD, Mearadji A, Breeman WA, Marquet RL, de Jong M, Krenning EP, et al. Somatostatin receptor imaging, therapy and new strategies in patients with neuroendocrine tumours. Br J Surg 88:31\u201340, 2001.","journal-title":"Br J Surg"},{"key":"14_CR17","first-page":"126","volume":"8","author":"GM Portela-Gomes","year":"2000","unstructured":"Portela-Gomes GM, Stridsberg M, Grimelius L, \u00d6berg K, Janson ET. Expression of the five different somatostatin receptor subtypes in endocrine cells of the pancreas. Appl Immunohistochem Mol Morphol 8:126\u201332, 2000.","journal-title":"Appl Immunohistochem Mol Morphol"},{"key":"14_CR18","first-page":"5969","volume":"50","author":"JC Reubi","year":"1990","unstructured":"Reubi JC, Kvols LK, Waser B, Nagorney DM, Heitz PU, Charboneau JW, et al. Detection of somatostatin receptors in surgical and percutaneous needle biopsy samples of carcinoids and islet cell carcinomas. Cancer Res 50:5969\u201377, 1990.","journal-title":"Cancer Res"},{"key":"14_CR19","first-page":"3445","volume":"54","author":"JC Reubi","year":"1994","unstructured":"Reubi JC, Schaer JC, Waser B, Mengod G. Expression and localization of somatostatin receptor SSTR1, SSTR2, and SSTR3 messenger RNAs in primary human tumors using in situ hybridization. Cancer Res 54:3455\u2013345, 1994.","journal-title":"Cancer Res"},{"key":"14_CR20","doi-asserted-by":"crossref","first-page":"1321","DOI":"10.1172\/JCI117090","volume":"93","author":"A Kubota","year":"1994","unstructured":"Kubota A, Yamada Y, Kagimoto S, Shimatsu A, Imamura M, Tsuda K, et al. Identification of somatostatin receptor subtypes and an implication for the efficacy of somatostatin analogue SMS 201-995 in treatment of human endocrine tumors. J Clin Invest 93:1321\u20135, 1994.","journal-title":"J Clin Invest"},{"key":"14_CR21","doi-asserted-by":"crossref","first-page":"639","DOI":"10.1046\/j.1365-2362.1997.1740719.x","volume":"27","author":"P Ja\u00efs","year":"1997","unstructured":"Ja\u00efs P, Terris B, Ruszniewski P, Leromancer M, Reyl-desmars F, Vissuzaine C, et al. Somatostatin receptor subtype gene expression in human endocrine gastroentero-pancreatic tumours. Eur J Clin Invest 27:639\u201344, 1997.","journal-title":"Eur J Clin Invest"},{"key":"14_CR22","doi-asserted-by":"crossref","first-page":"69","DOI":"10.1677\/erc.1.00962","volume":"13","author":"SV S\u00e1 de","year":"2006","unstructured":"de S\u00e1 SV, Corera-Giannella ML, Machado MC, de Souza JJS, Pereira MAA, Patzina RA, et al. Somatostatin receptor subtype 5 (SSTR5) mRNA expression is related to histopathological features of cell proliferation in insulinomas. Endocr Relat Cancer 13:69\u201378, 2006.","journal-title":"Endocr Relat Cancer"},{"key":"14_CR23","first-page":"2375","volume":"58","author":"ET Janson","year":"1998","unstructured":"Janson ET, Stridsberg M, Gobl A, Westlin JE, Oberg K. Determination of somatostatin receptor subtype 2 in carcinoid tumors by immunohistochemical investigation with somatostatin receptor subtype 2 antibodies. Cancer Res 58:2375\u20138, 1998.","journal-title":"Cancer Res"},{"key":"14_CR24","doi-asserted-by":"crossref","first-page":"3011","DOI":"10.1210\/jcem.82.9.4252","volume":"82","author":"LJ Hofland","year":"1997","unstructured":"Hofland LJ, De Herder WW, Visser-Wisselaar HA, van Uffelen C, Waaijers M, Zuyderwijk J, et al. Dissociation between the effects of somatostatin (SS) and octapeptide SS-analogs on hormone release in a small subgroup of pituitary- and islet cell tumors. J Clin Endocrinol Metab 82:3011\u20138, 1997.","journal-title":"J Clin Endocrinol Metab"},{"key":"14_CR25","doi-asserted-by":"crossref","first-page":"233","DOI":"10.1016\/S0002-9440(10)65564-2","volume":"153","author":"JC Reubi","year":"1998","unstructured":"Reubi JC, Kappeler A, Waser B, Laissue J, William Hipkin R, Schonbrunn A. Immunohistochemical localization of somatostatin receptors sst2A in human tumors. Am J Pathol 153:233\u201345, 1998.","journal-title":"Am J Pathol"},{"key":"14_CR26","doi-asserted-by":"crossref","first-page":"52","DOI":"10.1136\/gut.50.1.52","volume":"50","author":"H Kulaksiz","year":"2002","unstructured":"Kulaksiz H, Eissele R, Rossler D, Schulz S, H\u00f6llt V, Cetin Y, et al. Identification of somatostatin receptor subtypes 1, 2A, 3, and 5 in neuroendocrine tumours with subtype specific antibodies. Gut 50:52\u201360, 2002.","journal-title":"Gut"},{"key":"14_CR27","doi-asserted-by":"crossref","first-page":"461","DOI":"10.1007\/s00428-002-0609-x","volume":"440","author":"M Papotti","year":"2002","unstructured":"Papotti M, Bongiovanni M, Volante M, All\u00eca E, Landolfi S, Helboe L, et al. Expression of somatostatin receptor types 1\u20135 in 81 cases of gastrointestinal and pancreatic endocrine tumors. A correlative immunohistochemical and reverse-transcriptase polymerase chain reaction analysis. Virchows Archiv 440:461\u201375, 2002.","journal-title":"Virchows Archiv"},{"key":"14_CR28","doi-asserted-by":"crossref","first-page":"690","DOI":"10.1007\/s005950200128","volume":"32","author":"Y Oda","year":"2002","unstructured":"Oda Y, Tanaka Y, Naruse T, Sasanabe R, Tsubamoto M, Funahashi H. Expression of somatostatin receptor and effects of somatostatin analog on pancreatic endocrine tumors. Surg Today 32:690\u20134, 2002.","journal-title":"Surg Today"},{"key":"14_CR29","doi-asserted-by":"crossref","first-page":"5353","DOI":"10.1210\/jc.2002-021895","volume":"88","author":"J Bertherat","year":"2003","unstructured":"Bertherat J, Tenenbaum F, Perlemoine K, Videau C, Alberini JL, Richard B, et al. Somatostatin receptors 2 and 5 are the major somatostatin receptors in insulinomas: an in vivo and in vitro study. J Clin Endocrinol Metab 88:5353\u20136, 2003.","journal-title":"J Clin Endocrinol Metab"},{"key":"14_CR30","doi-asserted-by":"crossref","first-page":"577","DOI":"10.1177\/29.4.6166661","volume":"29","author":"SM Hsu","year":"1981","unstructured":"Hsu SM, Raine T, Fanger H. Use of avidin\u2013biotin\u2013peroxidase complex (ABC) in immmunoperoxidase techniques: a comparison between ABC and unlabeled (PAP) procedures. J Histochem Cytochem 29:577\u201380, 1981.","journal-title":"J Histochem Cytochem"},{"key":"14_CR31","doi-asserted-by":"crossref","first-page":"59","DOI":"10.1385\/MO:20:1:59","volume":"20","author":"ML Fj\u00e4llskog","year":"2003","unstructured":"Fj\u00e4llskog ML, Ludvigsen E, Stridsberg M, Oberg K, Eriksson B, Janson ET. Expression of somatostatin receptor subtypes 1 to 5 in tumor tissue and intratumoral vessels in malignant endocrine pancreatic tumors. Med Oncol 20:59\u201367, 2003.","journal-title":"Med Oncol"},{"key":"14_CR32","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1530\/eje.0.1510107","volume":"151","author":"SV Welin","year":"2004","unstructured":"Welin SV, Janson ET, Sundin A, Stridsberg M, Lavenius E, Granberg D, et al. High-dose treatment with a long-acting somatostatin analogue in patients with advanced midgut carcinoid tumours. Eur J Endocrinol 151:107\u201312, 2004.","journal-title":"Eur J Endocrinol"},{"key":"14_CR33","doi-asserted-by":"crossref","first-page":"2534","DOI":"10.1200\/JCO.1998.16.7.2534","volume":"16","author":"H Orlefors","year":"1998","unstructured":"Orlefors H, Sundin A, Ahlstrom H, Bjurling P, Bergstrom M, Lilja A, et al. Positron emission tomography with 5-hydroxytryptophan in neuroendocrine tumors. J Clin Oncol 16:2534\u201341, 1998.","journal-title":"J Clin Oncol"}],"container-title":["Endocrine Pathology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-007-0014-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s12022-007-0014-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s12022-007-0014-8","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,6,1]],"date-time":"2019-06-01T21:57:27Z","timestamp":1559426247000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s12022-007-0014-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2007,6,27]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2007,9,25]]}},"alternative-id":["14"],"URL":"https:\/\/doi.org\/10.1007\/s12022-007-0014-8","relation":{},"ISSN":["1046-3976","1559-0097"],"issn-type":[{"value":"1046-3976","type":"print"},{"value":"1559-0097","type":"electronic"}],"subject":[],"published":{"date-parts":[[2007,6,27]]}}}